Antiphospholipids in cutaneous vasculitis

Clinics in Dermatology

Volumn 17, Issue 6, 1999, Pages 619-624

  Gantcheva, Mary ^a   Angelova, Irena ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A; CARDIOLIPIN; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN; LUPUS ANTICOAGULANT; PHOSPHOLIPID; PHOSPHOLIPID ANTIBODY; PROTEIN C;

ANTIPHOSPHOLIPID SYNDROME; CLINICAL FEATURE; ENDOTHELIUM CELL; HUMAN; IMMUNOPATHOGENESIS; LEUKOCYTOCLASTIC VASCULITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; THROMBOSIS; VASCULITIS;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BIOLOGICAL MARKERS; HUMANS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; SKIN DISEASES, VASCULAR; VASCULITIS, HYPERSENSITIVITY;

EID: 0032740554     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(99)00067-X     Document Type: Review

References (66)

1. Petri M. Epidemiology of the antiphospholipid syndrome. Asherson R., Cervera R., Piette J., Shoenfeld Y. The antiphospholipid syndrome. 1996;13-28 CRC Press, Boca Raton, FL.
2. 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune diseases but not with infection. Lupus. 1:1992;75-81.
3. Conley C.L., Hartmann R.S. A hemorrhagic disorder caused by circulating anticoagulants in patients with disseminated lupus erythematosus. J Lab Clin Invest. 31:1952;621-622.
4. Feinstein D.I., Rapaport S.I. Acquired inhibitors of blood coagulation. Progr Haemostas Thromb. 1:1972;75-95.
5. Shoenfeld Y., Shaulian E., Berliner S., et al. Thromboembolic phenomenon in patients with lupus-type circulating anticoagulant. Rheumatologia. 51:1980;417-424.
6. Bevers E.M., Galli M., Barbui T., et al. Lupus anticoagulant IgG's are not directed to phospholipids only but to a complex of lipid-bound human prothrombin. Thromb Haemost. 66:1991;629-632.
7. Harris E.N., Gharavi A.E., Boey M.L., et al. Anticardiolopin antibodies Detection by radioimmunoassay and association with thrombosis and systemic lupus erythematosus . Lancet. 2:1983;1211-1214.
8. 2-glycoprotein I. Proc Natl Acad Sci USA. 87:1990;4120-4124.
9. Galli M., Confurius M., Maassen C., et al. Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein cofactor. Lancet. 335:1990;1544-1551.
10. Matsuura E., Igarashi Y., Fujimoto M., et al. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet. 336:1990;177-178.
11. 2-glycoprotein I Plasma inhibitor of contact activation of the intrinsic blood coagulation pathway . Blood. 66:1985;1086-1091.
12. 2-glycoprotein I. Thromb Haemost. 73:1995;798-804.
13. Shi W., Chong B., Hogg P., et al. Anticardiolipin antibodies block the inhibition of the factor Xa generating activity of platelets. Thromb Haemost. 70:1993;342-345.
14. 2-glycoprotein I. Biochem Biophys Acta. 884:1986;142-149.
15. 2-glycoprotein I with human blood platelets Influence upon the ADP-induced aggregation . Thromb Haemost. 54:1985;397-401.
16. 2-glycoprotein I modulates the anticoagulant activity of activated protein C on the phospholipid surface. Thromb Haemost. 75:1996;49-55.
17. Petri M. Pathogenesis and the treatment of the antiphospholipid syndrome. Adv Rheum. 81:1997;151-177.
18. Martinuzzo M.E., Maclouf J., Carreras L.O., et al. Antiphospholipid antibodies enhance thrombin-unduced platelet activation and thromboxan formation. Thromb Haemost. 70:1993;667-671.
19. Vismara A., Meroni P.L., Tincani A., et al. Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus. Clin Exp Immunol. 74:1988;247-253.
20. Del Papa N., Meroni P.L., Tincani A. Relationship between antiphospholipid and anti-endothelial cell antibodies Further characterization of the reactivity on testing and cytokine-activated endothelial cells . Clin Exp Rheum. 10:1992;37-42.
21. Ghirardello A., Doria A., Ruffatti A., et al. Antiphospholipid antibodies in systemic lupus erythematosus. Are they specific tools for the diagnosis of antiphospholipid syndrome? Ann Rheum Dis. 53:1994;140-142.
22. Wahl D., Guillemin F., De Maistre E., et al. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus - a meta-analysis. Lupus. 6:1997;467-473.
23. Nojima J., Suehisa E., Kuratsune H., et al. High prevalence of thrombocytopenia in systemic lupus erythematosus patients with a high level of anticardiolipin antibodies with lupus anticoagulant. Br J Haematol. 96:1997;447-450.
24. Rocca P.V., Siegel L.B., Cupps T.R. The concomitant expression of vasculitis and coagulopathy Synergy for marked tissue ischemia . J Rheumatol. 21:1994;556-560.
25. Alarcon-Segovia D., Cardiel M., Reyes E. Antiphospholipid arterial vasculopathy. J Rheumatol. 16:1989;762-767.
26. Lie J.T., Kobayashi S., Tokano Y., et al. Systemic and cerebral vasculitis coexisting with disseminated coagulopathy in systemic lupus erythematosus associated with antiphopspholipid syndrome. J Rheumatol. 22:1995;2173-2176.
27. Tanaka M., Kobayashi S., Tamura N., et al. Disseminated intravascular coagulation in a patient with systemic lupus erythematosus with lupus anticoagulant. Int Med. 32:1993;513-517.
28. Angles-Cano E., Sultan Y., Clauvel J.P. Predisposing factor to thrombosis in systemic lupus erythematosus. Possible relationship to endothelial cell damage. J Lab Clin Med. 94:1979;312-323.
29. Byron M., Allington M.J., Chapel H.M. Indication of vascular endothelial cell disfunction of systemic lupus erythematosus. Ann Rheum Dis. 46:1987;741-745.
30. Alarcon-Segovia D. Pathogenic potential of antiphospholipid antobodies. J Rheumatol. 15:1988;890-893.
31. Harris E.N., Gharavi A.E., Loizou S., et al. Cross-reactivity of antiphospholipid antibodies. J Clin Lab Immunol. 16:1985;1-6.
32. Bleil L., Manger B., Winkler T., et al. The role of antineutrophil cytoplasm antibodies, anticardiolipin antibodies, von Willebrand factor antigen and fibronectin for the diagnosis of systemic vasculitis. J Rheumatol. 18:1991;1199-1206.
33. Goldberger E., Elder R.C., Schwartz R.A., et al. Vasculitis in the antiphospholipid syndrome. A cause of ischemia responding to corticosteroids. Arthritis Rheum. 35:1992;569-572.
34. Herrick A.L., Oogacah P., Freemont A., et al. Vasculitis in patients with systemic sclerosis and severe digital ischemia requiring amputation. Ann Rheum Dis. 53:1994;323-326.
35. Herrick A.L., Oogacah P., Brammah T.B., et al. Nervous system involvement in association with vasculitis and anticardiolipin antibodies in a patient with systemic sclerosis. Ann Rheum Dis. 53:1994;349-354.
36. Keane A., Woods R., Dowding W., et al. Anticardiolipin antibodies in rheumatoid arthritis. Br J Rheumatol. 26:1987;346-350.
37. DeBrum-Fernandes A., Cossermelli-Messina W., Bueno C., et al. Anticardiolipin antibodies in rheumatoid arthritis. Clin Rheumatol. 8:1989;484-488.
38. Seriolo B., Cutolo M., Fasciolo D., et al. Anticardiolipin antibodies in rheumatoid artritis. Ann Rheum Dis. 51:1992;1100.
39. Wolf P., Gretler J., Aglas F., et al. Anticardiolipin antibodies in rheumatoid artriris Their relation to rheumatoid nodules and cutaneous vascular manifestations . Br J Dermatol. 131:1994;48-51.
40. Bergman N., Lorber M., Lerner M., et al. Anticardiolipin antibodies in Behçet's disease. J Rheumatol. 17:1990;164-167.
41. Gharavi A.E., Harris E.N., Asherson R., et al. Anticardiolipin antibodies Isotype distribution and phospholipid specificity . Ann Rheum Dis. 46:1987;1-6.
42. Ji H., Bang D., Lee S., et al. Anticardiolipin antibodies in patients with Behçet's disease. Ann Dermatol. 4:1992;1-8.
43. Hull R., Harris E.N., Gharavi A.E., et al. Anticardiolipin antibodies occurrence in Behçet's syndrome. Ann Rheum Dis. 43:1984;746-748.
44. Ozdemir Y., Onder F., Yarangumeli A., et al. Anticardiolipin antibodies and retinal vascular complications in Behçet's disease. Ophthalmic Surg Lasers. 28:1997;653-656.
45. Pivetti-Pezzi P., Priori R., Catarinelli J., et al. Markers of vascular injury in Behçet's disease associated with retinal vasculitis. Ann Ophthalmol. 24:1992;411-414.
46. Zouboulis C., Buttner P., Tebbe B., et al. Anticardiolipin antibodies in Adamantiades-Behçet's disease. Br J Dermatol. 128:1993;281-284.
47. Falcini F., Trapani S., Turchini S., et al. Immunological findings in Kawasaki disease An evaluation in cohort of Italian children . Clin Exp Rheumatol. 15:1997;685-689.
48. McHugh N.J., James I.E., Plant G.T. Anticardiolipin antibodies and antineutrophil antibodies in giant cell arteritis. J Rheumatol. 17:1990;916-922.
49. Manna R., Latteri M., Cristiano J., et al. Anticardiolipin antibodies in giant cell arteritis and polymyalgia rheumatica A study of 40 cases . Br J Rheumatol. 37:1998;208-210.
50. Duhaut P., Berrnyer M., Pinede L., et al. Anticardiolipin antibodies and giant cell arteritis A prospective, multicenter case-control study. Groupe de Recherche sur l' Arterites a Cellules Geantes . Arthritis Rheum. 41:1998;701-709.
51. Burden D., Tillman D., Foley P., et al. IgA class anticardiolipin antibodies in cutaneous leukocytoclastic vasculitis. J Am Acad Dermatol. 35:1996;411-415.
52. Burden D., Gibson I., Rodger R., et al. IgA anticardiolipin antibodies associated with Henoch-Schonlein purpura. J Am Acad Dermatol. 31:1994;857-860.
53. Lockshin M.D. Antiphospholipid antibody syndrome. JAMA. 268:1992;1451-1453.
54. Hamstan A., Norberg R., Bjorkholm M., et al. Antibodies to cardiolipin in young survivors of myocardial infarction An association with recurrent cardiovascular events . Lancet. 1:1986;113-115.
55. Cid M., Cervera R., Font J., et al. Recurrent arterial thrombosis in a patient with giant cell arteritis and raised anticardiolipin antibody levels. Br J Rheumatol. 27:1988;164-166.
56. Praderio L., D'Angelo A., Taccagni G., et al. Association of lupus anticoagulant with polyarteritis nodosa Report of a case . Haematologica. 75:1990;387-390.
57. Norden D.K., Ostrov B.E., Shafritz A.B., et al. Vasculitis associated with antiphospholipid syndrome. Semin Arthritis Rheum. 24:1995;273-281.
58. Dasgupta B., Almond M.K., Tanqueray A. Polyarteritis nodosa and the antiphospholipid syndrome. Br J Rheumatol. 36:1997;1210-1212.
59. Gantcheva M., Lalova A., Kamarashev J. Antiphospholipid syndrome associated with vasculitis. Curr Intern. 2/3:1996;22-23.
60. Lalova A., Popov J., Dourmishev A., et al. Dramatic vasculopathy in a patient with antiphospholipid syndrome. Acta Dermatol Venereol. 76:1996;406.
61. Lie J.T. Vasculitis in the antiphospholipid syndrome Culprit or consort? J Rheumatol. 21:1994;397-399.
62. Gertner E., Lie J.T. Pulmonary capillaritis, alveolar hemorrhage and recurrent microvascular thrombosis in primary antiphospholipid syndrome. J Rheumatol. 20:1993;1224-1228.
63. Crausman R.S., Achenbach G.A., Pluss W.T., et al. Pulmonary capillaritis and alveolar hemorrhage associated with the antiphospholipid antibody syndrome. J Rheumatol. 22:1995;554-556.
64. Papi M., Didona B., De Pita O., et al. PURPLE (atrophie blanche) A clinical histological and immunological study of 12 patients . J Eur Acad Dermatol Venereol. 9:1997;129-133.
65. Lotti T., Ghersetich I., Comacchi C., et al. Purpuras and related conditions. J Eur Acad Dermatol Venereol. 7:1996;7-25.
66. Lotti T., Ghersetich I., Comacchi C., et al. Cutaneous small-vessel vasculitis. J Am Acad Dermatol. 39:1998;667-687.